Apolipoprotein CI levels are associated with atherosclerosis in men with the metabolic syndrome and systemic inflammation

Atherosclerosis

Volumn 203, Issue 2, 2009, Pages 355-357

  van der Ham, R L M ^a   Dehnavi, R Alizadeh ^a   van den Berg, G A ^a   Putter, H ^a   de Roos, A ^a   Berbee J F P ^a   Romijn, J A ^a   Rensen, P C N ^a   Tamsma, J T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOENZYME; APOLIPOPROTEIN C1; APOLIPOPROTEIN C3; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; TRIGLYCERIDE RICH LIPOPROTEIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ANALYSIS OF VARIANCE; ARTERY INTIMA PROLIFERATION; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BINDING AFFINITY; BLOOD VESSEL; BODY MASS; CAROTID ARTERY; CLINICAL ASSESSMENT; DIAGNOSTIC IMAGING; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE COURSE; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; HEART VENTRICLE SEPTUM; HUMAN; INFLAMMATION; LABORATORY TEST; LETTER; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHENOTYPE; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC INFLAMMATION; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; APOLIPOPROTEIN C-I; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; DYSLIPIDEMIAS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; TRIGLYCERIDES;

EID: 62649093581     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.08.011     Document Type: Letter

References (16)

1. Shachter N.S. Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr Opin Lipidol 12 June (3) (2001) 297-304
2. Conde-Knape K., Bensadoun A., Sobel J.H., Cohn J.S., and Shachter N.S. Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase. J Lipid Res 43 December (12) (2002) 2136-2145
3. Berbee J.F., van der Hoogt C.C., Sundararaman D., Havekes L.M., and Rensen P.C. Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL. J Lipid Res 46 February (2) (2005) 297-306
4. Dumont L., Gautier T., de Barros J.P., et al. Molecular mechanism of the blockade of plasma cholesteryl ester transfer protein by its physiological inhibitor apolipoprotein CI. J Biol Chem 280 November (45) (2005) 38108-38116
5. Asztalos B.F., Schaefer E.J., Horvath K.V., et al. Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. J Lipid Res 48 March (3) (2007) 592-599
6. Hovingh G.K., Hutten B.A., Holleboom A.G., et al. Compromised LCAT function is associated with increased atherosclerosis. Circulation 112 August (6) (2005) 879-884
7. Bjorkegren J., Silveira A., Boquist S., et al. Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis. Arterioscler Thromb Vasc Biol 22 September (9) (2002) 1470-1474
8. Berbee J.F., van der Hoogt C.C., Kleemann R., et al. Apolipoprotein CI stimulates the response to lipopolysaccharide and reduces mortality in gram-negative sepsis. FASEB J 20 October (12) (2006) 2162-2164
9. Westerterp M., Berbee J.F., Pires N.M., et al. Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice. Circulation 116 November (19) (2007) 2173-2181
10. Hamsten A., Silveira A., Boquist S., et al. The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men. J Am Coll Cardiol 45 April (7) (2005) 1013-1017
11. Noto A.T., Mathiesen E.B., Brox J., Bjorkegren J., and Hansen J.B. The ApoC-I content of VLDL particles is associated with plaque size in persons with carotid atherosclerosis. Lipids May (2008)
12. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 September (9491) (2005) 1059-1062
13. Berbee J.F., Mooijaart S.P., de Craen A.J., et al. Plasma apolipoprotein CI protects against mortality from infection in old age. J Gerontol A Biol Sci Med Sci 63 February (2) (2008) 122-126
14. Schaap F.G., Nierman M.C., Berbee J.F., et al. Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia. J Lipid Res 47 October (10) (2006) 2333-2339
15. Schippers E.F., Berbee J.F., van D.I., et al. Preoperative apolipoprotein CI levels correlate positively with the proinflammatory response in patients experiencing endotoxemia following elective cardiac surgery. Intensive Care Med April (2008)
16. Alizadeh D.R., Doornbos J., Tamsma J.T., et al. Assessment of the carotid artery by MRI at 3T: a study on reproducibility. J Magn Reson Imaging 25 May (5) (2007) 1035-1043